President Trump signed an executive order last month on lowering the prices of prescription drugs. It proposes among other things a change to the Medicare drug pricing provision contained in the Inflation Reduction Act that could delay small molecule eligibility for negotiations by up to four years. Details regarding the exact time frame haven’t been […]
